Budget Impact Analysis of Utilization of Sacubitril/Valsartan for the Treatment of Heart Failure With Reduced Ejection Fraction in the Philippines.

Autor: Leong RN; metaHealth Insights and Innovations, Malabon, Philippines., Caesar Delos Trinos JP; metaHealth Insights and Innovations, Malabon, Philippines. Electronic address: paul.delostrinos@metahealth.net., Gerodias F Jr; metaHealth Insights and Innovations, Malabon, Philippines., Mojica VJ; metaHealth Insights and Innovations, Malabon, Philippines; University of the Philippines Manila, Manila, Philippines., Alconera CJ; metaHealth Insights and Innovations, Malabon, Philippines., Tamayo RL; metaHealth Insights and Innovations, Malabon, Philippines., Alacapa J; metaHealth Insights and Innovations, Malabon, Philippines., Almirol BJ; Novartis Healthcare Philippines, Inc, Makati City, Philippines., Paredes KP; Novartis Healthcare Philippines, Inc, Makati City, Philippines., Lim S; Novartis Healthcare Philippines, Inc, Makati City, Philippines., Tumanan-Mendoza B; Department of Internal Medicine, Manila Doctors Hospital, Manila, Philippines.

Publikováno v: Value in health regional issues [Value Health Reg Issues] 2023 Jul; Vol. 36, pp. 105-116. Date of Electronic Publication: 2023 Apr 25.

Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease.

Autor: Abola MTB; Department of Clinical Research, Philippine Heart Center and University of the Philippines College of Medicine., Golledge J; Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, and Department of Vascular and Endovascular Surgery, The Townsville Hospital., Miyata T; Vascular Center, Sanno Hospital and Sanno Medical Center., Rha SW; Dept of Cardiology, Internal Medicine, College of Medicine, Korea University; Cardiovascular Center, Korea University Guro Hospital., Yan BP; Division of Cardiology, Department of Medicine and Therapeutics,The Chinese University of Hong Kong, Prince of Wales Hospital., Dy TC; The Heart Institute, Chinese General Hospital and Medical Center., Ganzon MSV; Dr. HBCalleja Heart and Vascular Institute, St. Luke's Medical Center., Handa PK; Department of General Medicine, Tan Tock Seng Hospital., Harris S; Neurovascular and Neurosonology Division, Neurology Department, Universitas Indonesia, Cipto Mangunkusumo General Hospita., Zhisheng J; University of South China., Pinjala R; Apollo Hospitals., Robless PA; Robless Vascular Clinic., Yokoi H; Cardiovascular Center, Fukuoka Sanno Hospital; International University of Health and Welfare., Alajar EB; Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital; University of the Philippines College of Medicine., Bermudez-Delos Santos AA; Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital., Llanes EJB; Division of Cardiology, Department of Medicine, College of Medicine, University of the Philippines Philippine General Hospital., Obrado-Nabablit GM; Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital., Pestaño NS; Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital., Punzalan FE; Division of Cardiology, Department of Medicine, College of Medicine, University of the Philippines; Philippine General Hospital., Tumanan-Mendoza B; Department of Clinical Epidemiology, University of the Philippines College of Medicine.

Publikováno v: Journal of atherosclerosis and thrombosis [J Atheroscler Thromb] 2020 Dec 01; Vol. 27 (12), pp. 1374. Date of Electronic Publication: 2020 Nov 07.

A systematic review and meta-analysis on the effectiveness of an invasive strategy compared to a conservative approach in patients > 65 years old with non-ST elevation acute coronary syndrome.

Autor: Reaño JDP; Adult Cardiology, Manila Doctors Hospital, Manila, Philippines., Shiu LAB; Adult Cardiology, Manila Doctors Hospital, Manila, Philippines., Miralles KV; Adult Cardiology, Manila Doctors Hospital, Manila, Philippines., Dimalala MGC; Interventional Cardiology, Manila Doctors Hospital, Manila, Philippines., Pestaño NS; Adult Cardiology, Manila Doctors Hospital, Manila, Philippines., Punzalan FER; Adult Cardiology, Manila Doctors Hospital, Manila, Philippines.; Division of Cardiology, Department of Medicine, Philippine General Hospital, College of Medicine University of the Philippines, Manila, Philippines., Tumanan-Mendoza B; Adult Cardiology, Manila Doctors Hospital, Manila, Philippines., Reyes MJT; Adult Cardiology, Manila Doctors Hospital, Manila, Philippines.; Interventional Cardiology, Manila Doctors Hospital, Manila, Philippines., Castillo RR; Adult Cardiology, Manila Doctors Hospital, Manila, Philippines.; Cardiovascular Medicine, Adventist University of the Philippines, Silang, Philippines.; FAME Leaders Academy, Makati, Philippines.

Publikováno v: PloS one [PLoS One] 2020 Feb 27; Vol. 15 (2), pp. e0229491. Date of Electronic Publication: 2020 Feb 27 (Print Publication: 2020).

A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.

Autor: Yanai, Hidekatsu¹ (AUTHOR) dadachidm@hospk.ncgm.go.jp, Adachi, Hiroki¹ (AUTHOR), Hakoshima, Mariko¹ (AUTHOR), Iida, Sakura¹ (AUTHOR), Katsuyama, Hisayuki¹ (AUTHOR)

Publikováno v: Cells (2073-4409). Mar2024, Vol. 13 Issue 5, p450. 24p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.